REVOLUTIONARY DECISION-SUPPORT TECHNOLOGY FOR PATIENT-SPECIFIC INSULIN TREATMENT PLANS

Healthcare providers need to quickly analyze more raw information, of greater variety and precision, than ever before.There is a solution.

Just ask your Advisor.

DreaMed Advisor Pro Learns, Analyzes, and Optimizes

DreaMed Advisor Pro gets to know each patient’s habits, needs and glucose patterns, with historical and real-time data from diabetes management tools such as insulin pumps, glucose monitors, diet and personal information logs, and more. With unique, cloud-based adaptive artificial intelligence, Advisor Pro analyzes this wealth of information

and progressively refines its understanding of each case over time - emulating the way expert endocrinologists actually evaluate their patients. Complex patient data becomes actionable, real-time insights for personalized insulin treatment recommendations – which is the key to optimal health outcomes.

Presented at ATTD, Paris, Feb 2017 Presented at ATTD, Vienna, Feb 2018

Oct - Dec 2016

Jan - May 2017

DreaMed Advisor Pro - The Clinical Evidence Is In

Pilot clinical studies show: • Advisor Pro is statistically in agreement

with expert physicians to the same degree they are in agreement with each other.

• Advisor Pro is as good as expert diabetologists in controlling glucose levels. Nimri R et al, Diabetes Obes Metab. June 8, 2018

Feb - Nov 2017

DreaMed Advisor Pro is like a tireless, full-time insulin management consultant.

TimesavingEach office visit is far more focused and efficient. Less time spent unpacking data and more time on patient care.

Accessible anywhereFrequent remote consultations and updates. Therapy is responsive to real-time needs and behaviors.

With personalized, dynamic guidance, based on real-time patient behavior, the benefits and effectiveness of any insulin therapy increase exponentially.

Another expertClinicians can see more patients.Treatment is possible even when insulin pump therapy knowledge is lacking.

About DreaMedFounded in 2014, DreaMed Diabetes develops healthcare solutions and decision-support tools for the optimization of insulin therapy for people with Type 1 and Type 2 diabetes. The company is bringing glycemic control to patients everywhere, with personalized medicine that improves their quality of life and lowers their overall treatment costs. DreaMed products are currently in use in leading clinical centers in the European Union and the United States.

Advisor Pro HCP Brochure v.1, Dec 2018www.dreamed-diabetes.com

DreaMed Advisor Pro

THE EVOLUTION OF DIABETES CARE - DELIVERED AT THE SPEED OF LIFE